AFfirm™鼠单抗
Affinity自研鼠单克隆抗体AFfirm™系列,采用全新生产工艺,保证抗体特异性,抗体批次更稳定。
为什么选择AFfirm™鼠单抗?
货号 | 产品 | 来源 | 克隆 | 克隆号 | 反应 | 应用 | 引用 |
---|---|---|---|---|---|---|---|
BF8416 | AFfirm™ DKK1 mAb | Mouse | Monoclonal | AFfirm8416 | Human,Mouse,Rat | WB,IHC,IF/ICC | 0 |
BF8417 | AFfirm™ RSK2 mAb | Mouse | Monoclonal | AFfirm8417 | Human | WB | 0 |
BF8418 | AFfirm™ TrkC mAb | Mouse | Monoclonal | AFfirm8418 | Human,Mouse,Rat | WB | 0 |
BF8419 | AFfirm™ PSD95 mAb | Mouse | Monoclonal | AFfirm8419 | Human,Mouse | WB,IF/ICC | 0 |
BF8420 | AFfirm™ n-Myc mAb | Mouse | Monoclonal | AFfirm8420 | Human,Rat | WB | 0 |
BF8421 | AFfirm™ P-beta Catenin (Ser37) mAb | Mouse | Monoclonal | AFfirm8421 | Human,Mouse,Rat | WB | 0 |
BF8422 | AFfirm™ IRF3 mAb | Mouse | Monoclonal | AFfirm8422 | Human | IHC | 0 |
BF8423 | AFfirm™ Nucleophosmin mAb | Mouse | Monoclonal | AFfirm8423 | Human,Mouse,Rat | WB,IHC | 0 |
BF8424 | AFfirm™ AQP2 mAb | Mouse | Monoclonal | AFfirm8424 | Human,Mouse,Rat | WB,IHC,IF/ICC | 0 |
BF8425 | AFfirm™ P-STAT5 (Ser725/Ser730)[Ser726/Ser731] mAb | Mouse | Monoclonal | AFfirm8425 | Human | WB | 0 |
BF8426 | AFfirm™ P-IKK beta (Tyr188) mAb | Mouse | Monoclonal | AFfirm8426 | Human,Rat | WB,IF/ICC | 0 |
BF8427 | AFfirm™ MCM2 mAb | Mouse | Monoclonal | AFfirm8427 | Human,Rat | WB,IHC | 0 |
BF8428 | AFfirm™ ZIP7 mAb | Mouse | Monoclonal | AFfirm8428 | Human,Mouse,Rat | WB,IHC | 0 |
BF8429 | AFfirm™ MKK3/MKK6 mAb | Mouse | Monoclonal | AFfirm8429 | Human,Mouse,Rat | WB,IHC | 0 |
BF8430 | AFfirm™ PKD1/PKC mu mAb | Mouse | Monoclonal | AFfirm8430 | Human,Mouse,Rat | WB,IF/ICC | 0 |
BF8431 | AFfirm™ BID mAb | Mouse | Monoclonal | AFfirm8431 | Human,Mouse | WB,IF/ICC | 0 |
BF8432 | AFfirm™ FAS mAb | Mouse | Monoclonal | AFfirm8432 | Human,Rat | WB,IHC,IF/ICC | 0 |
BF8433 | AFfirm™ Hexokinase 1 mAb | Mouse | Monoclonal | AFfirm8433 | Human | WB | 0 |
BF8434 | AFfirm™ SOD2/MnSOD mAb | Mouse | Monoclonal | AFfirm8434 | Human,Mouse,Rat | WB,IF/ICC | 0 |
BF8435 | AFfirm™ P-Ezrin (Thr567) mAb | Mouse | Monoclonal | AFfirm8435 | Human,Rat | WB,IHC,IF/ICC | 0 |